On December 1, 2025, President Donald Trump signed the SUPPORT for Patients and Communities Reauthorization Act of 2025 into law. This legislation reauthorizes critical substance use disorder (SUD) prevention, treatment, and recovery programs through fiscal year 2030. The bipartisan passage in both the House and the Senate demonstrates a shared understanding of the urgent need to combat SUDs.
Some of the key provisions include:
- Support for individuals and families impacted by fetal alcohol spectrum disorder
- Support for residential treatment programs for pregnant and postpartum women (PPW)
- Mental and behavioral health education and training for medical and allied health students
- Technical assistance opportunities for peer support networks
At the Policy Center, we recognize the profound intersection of substance use disorders and maternal mental health. Pregnancy and postpartum periods can be incredibly vulnerable times, and the presence of SUDs often complicates and exacerbates co-occurring maternal mental health conditions. Untreated maternal mental and substance use disorders are linked to high-risk pregnancies, poor infant health outcomes, and maternal mortality. Effective recovery for mothers facing SUD and co-occurring mental health challenges requires a comprehensive, multi-faceted approach centered on integration and evidence-based care. While the reauthorization of the SUPPORT Act provides a crucial legislative framework, its impact will depend on two critical factors: whether the programs are fully appropriated and if the implementing agencies, including SAMHSA, are adequately staffed and resourced to execute the renewed initiatives through 2030. The path to comprehensive recovery and well-being, particularly for mothers and families, requires adequate resources and a sustained commitment to comprehensive SUD screening and integrated treatment.